Prudential CEO mulls shrinking ‘low growth’ businesses

NEW YORK: Prudential Financial Inc, which has already halted sales of some variable annuities, said that it will also consider scaling back its individual life insurance and other “market sensitive, low growth” businesses.

“Life will be one of the businesses we look at in addition to annuities but not the only one, ” said chief executive officer Charles Lowrey in a call with analysts to discuss the New Jersey insurer’s fourth-quarter results.

More insurers are selling off individual life insurance businesses. Large life insurance investment portfolios are highly sensitive to already low interest rates, which have dropped further during the pandemic, and dragged on industry earnings along with higher Covid-19 death rates.

Private equity firms see opportunity. Last month, Allstate Corp said it had agreed to sell most of its life insurance business to entities managed by buyout firm Blackstone Group Inc for US$2.8bil.

Last year, American International Group Inc said it will separate its life insurance business from the company.

In November, Prudential said that it would stop selling variable annuities with so-called “guaranteed living benefits, ” which for a fee offer features such as set minimum income for life or the ability to withdraw funds.

That move was also aimed at curbing the company’s interest rate risk.

Lowrey has said that Prudential would look at “blocks of businesses in terms of runoff, reinsurance or sales.” ─ Reuters

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3

Prudential , insurance , shrinking , businesses ,


Next In Business News

Malaysia Airlines extends flexibility for passengers to change travel dates
MAA: Vehicle sales up 33% to 63,878 units in March
FBM KLCI ends flat on lack of fresh catalysts
Grab considering secondary Singapore listing after US SPAC merger - sources
UEM Edgenta denies allegations, claims against its subsidiary by AZSB
Bank Negara revises foreign exchange notices
Tencent raises US$4.2bil in its second major bond deal in a year
World stocks near record highs as China, U.S. data back global recovery hopes
Oil steady climbs to four-week high on strong China data, demand revival
Sinopharm to inject US$4.6 bln vaccine assets into unit Tiantan Biological

Stories You'll Enjoy